Just as I thought.. How's 233 million shares for ya....

New Post Public Reply Private Reply Replies (0) Message Board
joey68
Just as I thought..

How's 233 million shares for ya.... in ONE day?

Think of the volume when the ticker symbol / name changes.

REVE Technologies, Inc. (BSSP) Stock Research Links

BSSP Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Investors Must Weigh Legal Options Now

Updated Category News Views 141

Pressure Mounts on Duolingo Amid Legal Turmoil Well, here's a riddle solved with a lawsuit: when an app's growth hits the brakes, the lawyers seem to get moving fast. It seems like Duolingo, Inc. (NasdaqGS: DUOL) is learning a harsh lesson—not exactly in Spanish or French, but in the courtroom. They've been slapped with a securities class action, and it ain't looking...

Continue Reading
ScienceOra Unveils AI Catalyst Design at Tencent Summit

Updated Category News Views 110

AI in Material Science: Beyond Buzzwords There's a lot of talk out there about AI changing the world, but it's always a different tune when it's put under a microscope. At the 2026 Tencent Global Digital Ecosystem Summit, ScienceOra and Wenge AI showcased an AI-assisted workflow for designing hydrogen-production catalysts. This isn't your average AI cheerleading session,...

Continue Reading
Race for Life Rescue Logs 200 Flights for Shelter Pets

Updated Category News Views 108

Airborne Lifelines for Vulnerable Animals Ever picture an airplane filled with hope? Well, Race for Life Rescue isn't just carting metal through the sky; they're lifting spirits, one furry passenger at a time. Picture this: a nonprofit turning a clunky Beechcraft into a flying ark, whisking away 112 at-risk pets from Louisiana to fresh starts in the Northeast. And guess...

Continue Reading
Alignment Healthcare Faces Investigation Over Alleged Fraud

Updated Category News Views 76

Rough Waters at Alignment Healthcare Not every day we hear about a company sinking its own ship over bookkeeping shenanigans, but here we are. Alignment Healthcare, sitting on Nasdaq under ticker ALHC, is facing the kind of scrutiny that sends shivers down a boardroom's spine. Yeah, Kahn Swick & Foti—those big hitters in securities litigation—have launched an...

Continue Reading
iTLC Traffic Systems Expand Global Reach at APTA 2026

Updated Category News Views 108

APTA 2026: The Launchpad for Intelligent Traffic Control Forget the days of manual traffic chaos—by the sounds of it, smart intersections are ready to rule the roads. Today's chatter at APTA 2026 in Chicago was a whirlwind of ideas, all centered around how ICP DAS and Towards Buddha Co., Ltd. plan to shake up traffic management globally with their iTLC Intelligent...

Continue Reading
Chemours Class Action: Key Deadline Approaches Fast

Updated Category News Views 77

A Rocky Ride for Chemours Investors The ticker might read NYSE:CC, but right now, that might as well stand for "Caution, Cautious," if you ask me. Investors are on high alert with Chemours facing a class action lawsuit, and the stakes couldn’t be higher. Deadline's looming on December 7, 2026, for those gunning for lead plaintiff status. It's a tense time for anyone who...

Continue Reading
Millrose Properties Faces Legal Storm: Investors Alerted

Updated Category News Views 187

Millrose Properties: A Storm's Brewing Whoa, step back and take a wide-eyed look at Millrose Properties—there’s a storm brewin’ and it’s a doozy! Right now, they’re up against one mighty class action lawsuit, and investors who’ve been hit for over $100k better circle December 8, 2026, on their calendars if they fancy a shot at lead plaintiff glory. We’re...

Continue Reading
CMRE Facing Legal Heat Over Wage Allegations

Updated Category News Views 96

Another Day, Another Lawsuit Ah, work. It’s what gets us up in the morning, whether we like it or not. Yet, for many, it can feel more like a dubious hustle when the rewards don't match the effort. Now, CMRE Financial Services, Inc. finds itself under the legal microscope, thanks to a fresh class-action lawsuit filed by the legal eagles at Blumenthal Nordrehaug Bhowmik...

Continue Reading
Zhimeng Biopharma Hits Key Milestone in ALS Drug Trial

Updated Category News Views 156

Pivotal Point for Zhimeng's ALS Efforts Folks, get this—Zhimeng Biopharma's rolling out the big guns here with a significant step forward in their ALS treatment quest. This company just wrapped up patient enrollment for their next-gen ALS drug, CB03-154. We're talking about 255 patients now on board for a Phase 2/3 trial. The ground's shaking a bit because this...

Continue Reading
Aemetis Faces Class Action Over Wage Violation Claims

Updated Category News Views 160

California's Alert: Labor Code Violations Under Scrutiny Allegations like these can shake things up pretty quick, especially when you're dealing with harsh financial climates. Aemetis Advanced Fuel Keyes, Inc. is in hot water yet again—this time, they're being called out for allegedly messing up the wage game for their workers. That's right, a class action lawsuit filed...

Continue Reading

Top 5 Most Recently Viewed Articles

Dental Implants Market Gains Momentum Towards $18B by 2031

Updated Category News Views 7

Dental Implants: Growing Market or Overhyped Bubble? In a world that's forever chewing over the latest industry trends, dental implants and prosthetics are racking up some hefty numbers. From a modest $12.79 billion in 2026, we're looking at a solid ramp-up to $17.67 billion come 2031—a respectable 6.7% CAGR, if fancy acronyms get you buzzing. But what's behind these...

Continue Reading
Scenthound and Humane Colorado Unite for New Dog Adoption Initiative

Updated Category News Views 316

Scenthound and Humane Colorado Unite for New Dog Adoption Initiative All Scenthound locations in Colorado have collaborated with Humane Colorado to unveil a new partnership through the Clean Start program. This exciting initiative provides every dog adopted from Humane Colorado with complimentary Basic Hygiene services at participating Scenthound locations across the...

Continue Reading
Tarsus Pharmaceuticals to Engage at Key Investor Events Soon

Updated Category News Views 140

Tarsus Pharmaceuticals to Engage with Investors at Upcoming Conferences IRVINE, Calif. — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) has exciting news for investors and stakeholders as it reveals plans to participate in several key investor conferences in the near future. These events present a golden opportunity for the team to share their latest advancements and...

Continue Reading
India Fund Inc. (IFN) Reaches 52-Week Low, What Next?

Updated Category News Views 168

India Fund Inc. (IFN) Hits 52-Week Low of $15.9 In a challenging economic climate, the India Fund Inc. (IFN) stock has recently hit a significant milestone, marking a 52-week low at $15.9. This price point serves as a critical benchmark for investors and analysts alike, indicating a fundamental shift in market conditions. With a current market capitalization of...

Continue Reading
Lovesac Earnings Preview: Insights into Growth and Challenges

Updated Category News Views 131

Lovesac's Upcoming Earnings Announcement Lovesac (NASDAQ: LOVE) is gearing up to release its latest quarterly earnings report shortly. Investors are keenly interested in the details leading up to this announcement, looking for indicators of the company's financial health and potential future growth. What Analysts Are Expecting Currently, analysts project that Lovesac will...

Continue Reading